Weight loss drugs could help people with alcohol addiction, study suggests
- A new study suggests that weight loss drugs like Ozempic could aid those with alcohol addiction, showing significant reduction in intoxication rates.
- The study authors recommend further investigation into these drugs as a treatment option for alcohol addiction.
38 Articles
38 Articles
Study Suggests Weight-Loss Drugs Like Ozempic May Help Alcoholism, Opioid Addiction
What doesn’t it cure? A new study suggests increasingly popular GLP-1 drugs — better known by the brand names Ozempic, Wegovy, and Mounjaro, and used to treat diabetes and obesity — could help cut opioid and alcohol abuse nearly in half. But, as with all early-days research, until there’s more evidence, GLP-1 makers will have to subsist on an all-you-can-eat buffet of optimism. A Mega Study in Contrasts The study, published in the peer-reviewed…
Researchers Think Popular Weight Loss Drugs Could Help Lower Opioid Overdose, Alcohol Intoxication Rates
Weight loss drugs such as Ozempic, Wegovy, and Mounjaro may lower opioid overdose and alcohol intoxication rates among opioid addicts and alcoholics
Weight-loss drugs may reduce opioid and alcohol abuse by up to 50%, study finds
Weight-loss drugs such as Ozempic, made by Denmark’s Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer greater benefits than just weight and diabetes management.
Ozempic could help with opioid and alcohol abuse, new research shows
This is the second study this fall to suggest that GLP-1s, such as Novo Nordisk’s Ozempic and Wegovy or Eli Lilly’s Mounjaro and Zepbound, have the ability to revolutionize the drug treatment options for people addicted to drugs or alcohol. Here is everything to know about how these drugs could improve addiction recovery. What... The post Ozempic could help with opioid and alcohol abuse, new research shows appeared first on Daily Truth Report …
Ozempic May Fight Alcohol and Opioid Addiction, Study Suggests
Ozempic may have even more uses than initially thought. A new study that appeared in the scientific journal Addiction found that GIP/GLP-1 receptor agonist medications, traditionally used to treat diabetes and promote weight loss, may also help people stop using drugs and drinking alcohol. A research team used data from Oracle Health’s Real-World Data repository to conduct the study, which looked at over 1,000,000 people. Researchers found that…
Coverage Details
Bias Distribution
- 74% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium

















